• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.27%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    113.93 Down 0.15(0.13%) 2:02PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:114.08
    Open:113.95
    Bid:114.08 x 700
    Ask:114.11 x 300
    1y Target Est:121.49
    Beta:0.93
    Earnings Date:Jul 21 - Jul 27 (Est.)
    Day's Range:113.14 - 114.20
    52wk Range:78.50 - 116.83
    Volume:5,978,824
    Avg Vol (3m):11,079,900
    Market Cap:167.43B
    P/E (ttm):12.99
    EPS (ttm):8.77
    Div & Yield:1.72 (1.50%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 0.13%167.43B
    GSKUp 0.59%107.25B
    PFEUp 0.06%212.93B
    RHHBYDown 0.27%N/A

    Key Statistics

    Forward P/E (1 yr):10.34
    P/S (ttm):6.10
    Ex-Dividend Date:12-Jun-15

    Analysts

    Annual EPS Est (Dec-15) :10.84
    Quarterly EPS Est (Jun-15) :2.66
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):0.79

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback